Aspectos farmacológicos prácticos de las drogas para el tratamiento de la tuberculosis drogorresistente en adultos y pediatría

Palmero, Domingo; Lagrutta, Laura; Aidar, Omar; Bartoletti, Bruno; Cruz, Víctor; Gamberale, Ana; García, Ana; González Montaner, Pablo; Inwentarz, Sandra; Vescovo, Marisa.
Rev. am. med. respir ; 22(2): 180-185, jun. 2022. graf
Artículo en Español | LILACS, BINACIS | ID: biblio-1441126

Documentos relacionados

  1. Practical Pharmacological Aspects of Drugs Used for the Treatment of Drug-Resistant Tuberculosis in Adults and Children
  2. Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.
  3. Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
  4. Improving the Antimycobacterial Drug Clofazimine through Formation of Organic Salts by Combination with Fluoroquinolones.
  5. Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.
  6. Avances en el tratamiento de la tuberculosis multirresistente
  7. Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
  8. Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
  9. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
  10. Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis.